164 related articles for article (PubMed ID: 8623488)
1. Combined rapamycin and cyclosporine immunosuppression in a porcine renal transplant model.
Granger DK; Cromwell JW; Canafax DM; Matas AJ
Transplant Proc; 1996 Apr; 28(2):984. PubMed ID: 8623488
[No Abstract] [Full Text] [Related]
2. Rapamycin in a porcine renal transplant model.
Almond PS; Moss A; Nakhleh R; Melin M; Chen S; Salazar A; Shirabe K; Matas A
Transplant Proc; 1993 Feb; 25(1 Pt 1):716. PubMed ID: 8438452
[No Abstract] [Full Text] [Related]
3. Triple combination of cyclosporine, brequinar, and rapamycin prolongs kidney allograft survival in the mongrel dog.
Ferraresso M; Knight R; Tu Y; Stepkowski SM; Kahan BD
Transplant Proc; 1994 Oct; 26(5):3028. PubMed ID: 7940953
[No Abstract] [Full Text] [Related]
4. Concentration-controlled immunosuppressive regimens using cyclosporine with sirolimus or brequinar in human renal transplantation.
Kahan BD
Transplant Proc; 1995 Feb; 27(1):33-6. PubMed ID: 7879019
[No Abstract] [Full Text] [Related]
5. Rapamycin and cyclosporine synergistically prolong heart and kidney allograft survival.
Stepkowski SM; Kahan BD
Transplant Proc; 1991 Dec; 23(6):3262-4. PubMed ID: 1750091
[No Abstract] [Full Text] [Related]
6. Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice.
Stepkowski SM; Tu Y; Chou TC; Kahan BD
Transplant Proc; 1994 Oct; 26(5):3025-7. PubMed ID: 7940952
[No Abstract] [Full Text] [Related]
7. Synergistic prolongation of renal allograft survival with cyclosporine and rapamycin.
Robertson A; Plenter R; Francis DM; Clunie GJ
Transplant Proc; 1993 Oct; 25(5):2898-9. PubMed ID: 8212279
[No Abstract] [Full Text] [Related]
8. A randomized, double-blind, placebo-controlled study to determine safety, tolerance, and preliminary pharmacokinetics of ascending single doses of orally administered sirolimus (rapamycin) in stable renal transplant recipients.
Brattström C; Tydén G; Säwe J; Herlenius G; Claesson K; Groth CG
Transplant Proc; 1996 Apr; 28(2):985-6. PubMed ID: 8623489
[No Abstract] [Full Text] [Related]
9. Low-dose rapamycin potentiates the effects of subtherapeutic doses of cyclosporine to prolong renal allograft survival in the mongrel canine model.
Knight R; Ferraresso M; Serino F; Katz S; Lewis R; Kahan BD
Transplantation; 1993 Apr; 55(4):947-9. PubMed ID: 8475571
[No Abstract] [Full Text] [Related]
10. Porcine small bowel transplantation with rapamycin-based induction immunosuppression and short-course cyclosporine or FK 506 therapy.
Cohen DS; Fisher RA; Shapiro JH; Goggins WC; Tawes JW; Mills S; Contos M; Ham JM; Schroeder TJ
Transplant Proc; 1996 Oct; 28(5):2501-5. PubMed ID: 8907923
[No Abstract] [Full Text] [Related]
11. Efficacy of rapamycin in orthotopic small bowel transplantation in the rat.
Marquet RL; de Bruin RW; Heineman E; Jeekel J
Transplant Proc; 1993 Aug; 25(4):2695-6. PubMed ID: 8356718
[No Abstract] [Full Text] [Related]
12. Comparison of rapamycin, RS 61443, cyclosporine, and low-dose heparin as treatment for transplant vasculopathy in a rat model of chronic allograft rejection.
Schmid C; Heemann U; Azuma H; Tilney NL
Transplant Proc; 1995 Feb; 27(1):438-9. PubMed ID: 7879053
[No Abstract] [Full Text] [Related]
13. Synergistic effect of 3M KCl-extracted donor antigens with cyclosporine or cyclosporine/rapamycin to prolong heart allograft survival in rats.
Hamashima T; Stepkowski SM; Smith S; Kahan BD
Transplant Proc; 1994 Oct; 26(5):3053-5. PubMed ID: 7940960
[No Abstract] [Full Text] [Related]
14. Prolongation of renal allograft survival in a large animal model by oral rapamycin monotherapy.
Granger DK; Cromwell JW; Chen SC; Goswitz JJ; Morrow DT; Beierle FA; Sehgal SN; Canafax DM; Matas AJ
Transplantation; 1995 Jan; 59(2):183-6. PubMed ID: 7839438
[TBL] [Abstract][Full Text] [Related]
15. Rapamycin: immunosuppression, hyporesponsiveness, and side effects in a porcine renal allograft model.
Almond PS; Moss A; Nakhleh RE; Melin M; Chen S; Salazar A; Shirabe K; Matas AJ
Transplantation; 1993 Aug; 56(2):275-81. PubMed ID: 8356580
[TBL] [Abstract][Full Text] [Related]
16. Effective and safe use of FK 506: combination treatment with rapamycin or RS-61443 in experimental organ transplantation.
Ochiai T; Gunji Y; Nagata M; Asano T; Isono K
Transplant Proc; 1991 Dec; 23(6):2718-9. PubMed ID: 1721255
[No Abstract] [Full Text] [Related]
17. Progressive change in tolerance mechanisms after withdrawing combination immunosuppression with cyclosporine and rapamycine or leflunomide.
Lin Y; Waer M
Transplant Proc; 1996 Dec; 28(6):3159. PubMed ID: 8962224
[No Abstract] [Full Text] [Related]
18. Synergistic effect of rapamycin and cyclosporine in pancreaticoduodenal transplantation in the rat.
Chen H; Wu J; Luo H; Daloze P
Transplant Proc; 1992 Jun; 24(3):892-3. PubMed ID: 1604658
[No Abstract] [Full Text] [Related]
19. Prolongation of skin allograft survival in mice treated with CTLA-4 Ig in combination with rapamycin or cyclosporine.
Hale DA; Gottschalk R; Wood ML; Maki T; Monaco AP
Transplant Proc; 1996 Dec; 28(6):3270-1. PubMed ID: 8962270
[No Abstract] [Full Text] [Related]
20. Rapamycin in experimental renal allografts in primates.
Collier DS; Calne RY; Pollard SG; Friend PJ; Thiru S
Transplant Proc; 1991 Aug; 23(4):2246-7. PubMed ID: 1871861
[No Abstract] [Full Text] [Related]
[Next] [New Search]
